Issued Patents All Time
Showing 1–21 of 21 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10793628 | Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy | Jin-Yuh Shew, Che Ma, Chia-Lin Chen, Wen-Hsin Lee, Chun-Kai Huang +1 more | 2020-10-06 |
| 10730864 | RAD51 inhibitors and uses thereof | Jiewen Zhu, Hongyuan Chen, Xuning Guo, Xiao-Long Qiu | 2020-08-04 |
| 10421753 | RAD51 inhibitors and uses thereof | Jiewen Zhu, Hongyuan Chen, Xuning Guo, Xiao-Long Qiu | 2019-09-24 |
| 9670197 | Small molecule modifiers of the Hec1-Nek2 interaction in G2/M | Jiewen Zhu, Chun-Mei Hu | 2017-06-06 |
| 9422275 | Small molecule modifiers of the HEC1-NEK2 interaction in G2/M | Jiewen Zhu, Chun-Mei Hu | 2016-08-23 |
| 9012455 | Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof | Phang-Lang Chen, Longen Zhou, Jiewen Zhu | 2015-04-21 |
| 8293764 | Compositions and methods for disruption of BRCA2-Rad51 interaction | Phang-Lang Chen, Jiewen Zhu | 2012-10-23 |
| 8252520 | Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases | Phang-Lang Chen, Yumay Chen | 2012-08-28 |
| 7105156 | Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells | H. Michael Shepard, Richard Gregory, Ken Wills, Daniel C. Maneval, Eva Lee +2 more | 2006-09-12 |
| 7060688 | Products and methods for controlling the suppression of the neoplastic phenotype | Huei-Jen Su Huang, Eva Lee, Theodore Friedmann, Jiing-Kuan Yee | 2006-06-13 |
| 6133424 | ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility gene product | Eva Y. -H. P. Lee | 2000-10-17 |
| 6051396 | Method for producing retinoblastoma gene protein products | Eva Lee | 2000-04-18 |
| 5998134 | Retinoblastoma gene-cancer suppressor and regulator | Eva Lee | 1999-12-07 |
| 5858771 | Products and methods for controlling the suppression of the neoplastic phenotype | Huei-Jen Su Huang, Eva Lee | 1999-01-12 |
| 5851991 | Therapeutic use of the retinoblastoma susceptibility gene product | Eva Lee, David Goodrich, H. Michael Shepard, Nan Wang, Duane E. Johnson | 1998-12-22 |
| 5821070 | Antibodies reactive with retinoblastoma binding proteins and methods of using same | Bei Shan | 1998-10-13 |
| 5710022 | Nuclear mitotic phosphoprotein | Xueling Zhu | 1998-01-20 |
| 5578701 | ppRB.sup.110 - nuclear phosphoprotein - the retinoblastoma susceptibility gene product | Eva Lee | 1996-11-26 |
| 5532220 | Genetic mechanisms of tumor suppression | Phang-Lang Chen | 1996-07-02 |
| 5011773 | Human esterase D, its uses and a process of purification | Eva Y. H. P. Lee | 1991-04-30 |
| 4942123 | ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product | Eva Lee | 1990-07-17 |